Annual Net Income
$8.03 B
+$1.70 B+26.84%
31 December 2023
Summary:
Bristol-Myers Squibb annual net profit is currently $8.03 billion, with the most recent change of +$1.70 billion (+26.84%) on 31 December 2023. During the last 3 years, it has risen by +$17.04 billion (+189.02%). BMY annual net income is now -24.38% below its all-time high of $10.61 billion, reached on 31 December 2009.BMY Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$1.21 B
-$469.00 M-27.92%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly net profit is currently $1.21 billion, with the most recent change of -$469.00 million (-27.92%) on 30 September 2024. Over the past year, it has dropped by -$717.00 million (-37.19%). BMY quarterly net income is now -84.91% below its all-time high of $8.03 billion, reached on 31 December 2009.BMY Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$7.26 B
-$717.00 M-10.96%
30 September 2024
Summary:
Bristol-Myers Squibb TTM net profit is currently -$7.26 billion, with the most recent change of -$717.00 million (-10.96%) on 30 September 2024. Over the past year, it has dropped by -$15.54 billion (-187.60%). BMY TTM net income is now -167.72% below its all-time high of $10.72 billion, reached on 31 March 2010.BMY TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.8% | -37.2% | -187.6% |
| 3 y3 years | +189.0% | -21.7% | -34.3% |
| 5 y5 years | +63.1% | -10.5% | -228.3% |
BMY Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +189.0% | -49.0% | +110.2% | -187.6% | at low |
| 5 y | 5 years | at high | +189.0% | -49.0% | +110.2% | -187.6% | +19.5% |
| alltime | all time | -24.4% | +189.0% | -84.9% | +110.2% | -167.7% | +19.5% |
Bristol-Myers Squibb Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.21 B(-27.9%) | -$7.26 B(+11.0%) |
| June 2024 | - | $1.68 B(-114.1%) | -$6.54 B(+6.4%) |
| Mar 2024 | - | -$11.91 B(-776.0%) | -$6.15 B(-176.6%) |
| Dec 2023 | $8.03 B(+26.8%) | $1.76 B(-8.6%) | $8.03 B(-3.1%) |
| Sept 2023 | - | $1.93 B(-7.0%) | $8.29 B(+4.0%) |
| June 2023 | - | $2.07 B(-8.4%) | $7.96 B(+8.9%) |
| Mar 2023 | - | $2.26 B(+11.9%) | $7.31 B(+15.6%) |
| Dec 2022 | $6.33 B(-9.5%) | $2.02 B(+25.9%) | $6.33 B(-5.2%) |
| Sept 2022 | - | $1.61 B(+13.0%) | $6.68 B(+0.9%) |
| June 2022 | - | $1.42 B(+11.2%) | $6.62 B(+5.9%) |
| Mar 2022 | - | $1.28 B(-46.1%) | $6.25 B(-10.6%) |
| Dec 2021 | $6.99 B(-177.6%) | $2.37 B(+53.4%) | $6.99 B(-229.4%) |
| Sept 2021 | - | $1.55 B(+46.5%) | -$5.41 B(+6.4%) |
| June 2021 | - | $1.05 B(-47.8%) | -$5.08 B(-18.3%) |
| Mar 2021 | - | $2.02 B(-120.2%) | -$6.22 B(-31.0%) |
| Dec 2020 | -$9.02 B(-362.1%) | -$10.03 B(-635.6%) | -$9.02 B(>+9900.0%) |
| Sept 2020 | - | $1.87 B(-2302.4%) | -$44.00 M(-92.2%) |
| June 2020 | - | -$85.00 M(-89.0%) | -$563.00 M(-159.0%) |
| Mar 2020 | - | -$775.00 M(-26.6%) | $954.00 M(-72.3%) |
| Dec 2019 | $3.44 B(-30.1%) | -$1.06 B(-178.0%) | $3.44 B(-39.2%) |
| Sept 2019 | - | $1.35 B(-5.5%) | $5.66 B(-8.8%) |
| June 2019 | - | $1.43 B(-16.3%) | $6.20 B(+20.6%) |
| Mar 2019 | - | $1.71 B(+47.4%) | $5.14 B(+4.6%) |
| Dec 2018 | $4.92 B(+388.6%) | $1.16 B(-39.0%) | $4.92 B(+243.6%) |
| Sept 2018 | - | $1.90 B(+409.7%) | $1.43 B(+280.9%) |
| June 2018 | - | $373.00 M(-74.9%) | $376.00 M(-59.1%) |
| Mar 2018 | - | $1.49 B(-163.8%) | $919.00 M(-8.7%) |
| Dec 2017 | $1.01 B(-77.4%) | -$2.33 B(-375.5%) | $1.01 B(-76.2%) |
| Sept 2017 | - | $845.00 M(-7.8%) | $4.23 B(-7.8%) |
| June 2017 | - | $916.00 M(-41.8%) | $4.59 B(-5.2%) |
| Mar 2017 | - | $1.57 B(+76.1%) | $4.84 B(+8.5%) |
| Dec 2016 | $4.46 B(+184.8%) | $894.00 M(-25.6%) | $4.46 B(+32.4%) |
| Sept 2016 | - | $1.20 B(+3.1%) | $3.37 B(+17.3%) |
| June 2016 | - | $1.17 B(-2.4%) | $2.87 B(+82.3%) |
| Mar 2016 | - | $1.20 B(-706.6%) | $1.57 B(+0.6%) |
| Dec 2015 | $1.56 B(-21.9%) | -$197.00 M(-127.9%) | $1.56 B(-11.8%) |
| Sept 2015 | - | $706.00 M(-643.1%) | $1.77 B(-0.8%) |
| June 2015 | - | -$130.00 M(-111.0%) | $1.79 B(-20.6%) |
| Mar 2015 | - | $1.19 B(+9023.1%) | $2.25 B(+12.4%) |
| Dec 2014 | $2.00 B(-21.8%) | $13.00 M(-98.2%) | $2.00 B(-26.2%) |
| Sept 2014 | - | $721.00 M(+116.5%) | $2.72 B(+1.1%) |
| June 2014 | - | $333.00 M(-64.5%) | $2.69 B(-7.0%) |
| Mar 2014 | - | $937.00 M(+29.1%) | $2.89 B(+12.8%) |
| Dec 2013 | $2.56 B(+30.8%) | $726.00 M(+4.9%) | $2.56 B(-7.2%) |
| Sept 2013 | - | $692.00 M(+29.1%) | $2.76 B(+103.2%) |
| June 2013 | - | $536.00 M(-12.0%) | $1.36 B(-7.4%) |
| Mar 2013 | - | $609.00 M(-34.2%) | $1.47 B(-25.1%) |
| Dec 2012 | $1.96 B(-47.2%) | $925.00 M(-230.1%) | $1.96 B(+3.9%) |
| Sept 2012 | - | -$711.00 M(-210.2%) | $1.89 B(-47.1%) |
| June 2012 | - | $645.00 M(-41.4%) | $3.57 B(-6.7%) |
| Mar 2012 | - | $1.10 B(+29.2%) | $3.82 B(+3.1%) |
| Dec 2011 | $3.71 B(+19.6%) | $852.00 M(-12.1%) | $3.71 B(+11.0%) |
| Sept 2011 | - | $969.00 M(+7.4%) | $3.34 B(+0.6%) |
| June 2011 | - | $902.00 M(-8.5%) | $3.32 B(-0.7%) |
| Mar 2011 | - | $986.00 M(+104.1%) | $3.35 B(+7.8%) |
| Dec 2010 | $3.10 B(-70.8%) | $483.00 M(-49.1%) | $3.10 B(-70.9%) |
| Sept 2010 | - | $949.00 M(+2.4%) | $10.64 B(-0.2%) |
| June 2010 | - | $927.00 M(+24.8%) | $10.66 B(-0.5%) |
| Mar 2010 | - | $743.00 M(-90.7%) | $10.72 B(+1.0%) |
| Dec 2009 | $10.61 B(+102.2%) | $8.03 B(+730.7%) | $10.61 B(+177.0%) |
| Sept 2009 | - | $966.00 M(-1.7%) | $3.83 B(-29.6%) |
| June 2009 | - | $983.00 M(+54.1%) | $5.44 B(+4.2%) |
| Mar 2009 | - | $638.00 M(-48.7%) | $5.22 B(-0.4%) |
| Dec 2008 | $5.25 B(+142.4%) | $1.24 B(-51.7%) | $5.25 B(+34.1%) |
| Sept 2008 | - | $2.58 B(+237.4%) | $3.91 B(+78.4%) |
| June 2008 | - | $764.00 M(+15.6%) | $2.19 B(+2.7%) |
| Mar 2008 | - | $661.00 M(-842.7%) | $2.14 B(-1.3%) |
| Dec 2007 | $2.17 B(+36.6%) | -$89.00 M(-110.4%) | $2.17 B(+2.1%) |
| Sept 2007 | - | $858.00 M(+21.5%) | $2.12 B(+32.5%) |
| June 2007 | - | $706.00 M(+2.3%) | $1.60 B(+2.5%) |
| Mar 2007 | - | $690.00 M(-614.9%) | $1.56 B(-1.5%) |
| Dec 2006 | $1.58 B(-47.2%) | -$134.00 M(-139.6%) | $1.58 B(-28.5%) |
| Sept 2006 | - | $338.00 M(-49.3%) | $2.22 B(-22.0%) |
| June 2006 | - | $667.00 M(-6.6%) | $2.84 B(-10.6%) |
| Mar 2006 | - | $714.00 M(+43.1%) | $3.18 B(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | $3.00 B(+25.6%) | $499.00 M(-48.2%) | $3.00 B(+13.6%) |
| Sept 2005 | - | $964.00 M(-4.0%) | $2.64 B(+8.5%) |
| June 2005 | - | $1.00 B(+88.4%) | $2.43 B(+24.4%) |
| Mar 2005 | - | $533.00 M(+283.5%) | $1.96 B(-18.0%) |
| Dec 2004 | $2.39 B(-23.1%) | $139.00 M(-81.7%) | $2.39 B(-13.3%) |
| Sept 2004 | - | $758.00 M(+43.8%) | $2.75 B(-5.1%) |
| June 2004 | - | $527.00 M(-45.3%) | $2.90 B(-11.4%) |
| Mar 2004 | - | $964.00 M(+90.5%) | $3.28 B(+5.5%) |
| Dec 2003 | $3.11 B(+45.3%) | $506.00 M(-44.2%) | $3.11 B(+2.0%) |
| Sept 2003 | - | $906.00 M(+0.4%) | $3.04 B(+22.0%) |
| June 2003 | - | $902.00 M(+13.9%) | $2.50 B(+20.4%) |
| Mar 2003 | - | $792.00 M(+78.0%) | $2.07 B(-3.0%) |
| Dec 2002 | $2.14 B(-55.8%) | $445.00 M(+24.6%) | $2.14 B(-28.2%) |
| Sept 2002 | - | $357.00 M(-25.5%) | $2.98 B(-21.8%) |
| June 2002 | - | $479.00 M(-44.0%) | $3.81 B(-15.9%) |
| Mar 2002 | - | $856.00 M(-33.3%) | $4.53 B(-9.6%) |
| Dec 2001 | $4.83 B(+2.6%) | $1.28 B(+8.2%) | $5.01 B(+2.5%) |
| Sept 2001 | - | $1.19 B(-1.2%) | $4.89 B(-1.0%) |
| June 2001 | - | $1.20 B(-10.1%) | $4.94 B(+2.3%) |
| Mar 2001 | - | $1.34 B(+14.9%) | $4.83 B(+2.4%) |
| Dec 2000 | $4.71 B(+13.1%) | $1.16 B(-5.9%) | $4.71 B(+2.4%) |
| Sept 2000 | - | $1.24 B(+13.3%) | $4.60 B(+3.1%) |
| June 2000 | - | $1.09 B(-10.6%) | $4.46 B(+3.2%) |
| Mar 2000 | - | $1.22 B(+16.1%) | $4.32 B(+3.7%) |
| Dec 1999 | $4.17 B(+32.7%) | $1.05 B(-4.1%) | $4.17 B(+18.1%) |
| Sept 1999 | - | $1.10 B(+15.2%) | $3.53 B(+3.9%) |
| June 1999 | - | $952.00 M(-10.7%) | $3.40 B(+3.6%) |
| Mar 1999 | - | $1.07 B(+158.1%) | $3.28 B(+4.4%) |
| Dec 1998 | $3.14 B(-2.0%) | $413.00 M(-57.2%) | $3.14 B(-11.0%) |
| Sept 1998 | - | $966.00 M(+15.7%) | $3.53 B(+3.2%) |
| June 1998 | - | $835.00 M(-9.9%) | $3.42 B(+2.9%) |
| Mar 1998 | - | $927.00 M(+15.6%) | $3.32 B(+3.7%) |
| Dec 1997 | $3.21 B(+12.5%) | $802.00 M(-6.2%) | $3.21 B(+2.8%) |
| Sept 1997 | - | $855.00 M(+15.9%) | $3.12 B(+3.4%) |
| June 1997 | - | $738.00 M(-8.9%) | $3.02 B(+2.8%) |
| Mar 1997 | - | $810.00 M(+13.1%) | $2.93 B(+2.9%) |
| Dec 1996 | $2.85 B(+57.3%) | $716.00 M(-4.9%) | $2.85 B(+43.1%) |
| Sept 1996 | - | $753.00 M(+15.0%) | $1.99 B(+3.3%) |
| June 1996 | - | $655.00 M(-9.8%) | $1.93 B(+2.5%) |
| Mar 1996 | - | $726.00 M(-611.3%) | $1.88 B(+3.8%) |
| Dec 1995 | $1.81 B(-1.6%) | -$142.00 M(-120.6%) | $1.81 B(-11.7%) |
| Sept 1995 | - | $689.00 M(+13.3%) | $2.05 B(+3.4%) |
| June 1995 | - | $608.00 M(-7.5%) | $1.98 B(+3.4%) |
| Mar 1995 | - | $657.00 M(+570.4%) | $1.92 B(+4.1%) |
| Dec 1994 | $1.84 B(-6.0%) | $98.00 M(-84.2%) | $1.84 B(-7.9%) |
| Sept 1994 | - | $621.00 M(+14.6%) | $2.00 B(+0.7%) |
| June 1994 | - | $542.00 M(-6.7%) | $1.99 B(+1.1%) |
| Mar 1994 | - | $581.00 M(+127.0%) | $1.97 B(+0.3%) |
| Dec 1993 | $1.96 B(-0.2%) | $256.00 M(-57.9%) | $1.96 B(-4.0%) |
| Sept 1993 | - | $608.00 M(+16.7%) | $2.04 B(+0.9%) |
| June 1993 | - | $521.00 M(-9.4%) | $2.02 B(+1.7%) |
| Mar 1993 | - | $575.00 M(+70.6%) | $1.99 B(+1.4%) |
| Dec 1992 | $1.96 B(-4.6%) | $337.00 M(-42.8%) | $1.96 B(-8.1%) |
| Sept 1992 | - | $589.00 M(+20.7%) | $2.13 B(+1.2%) |
| June 1992 | - | $488.00 M(-10.9%) | $2.11 B(-0.1%) |
| Mar 1992 | - | $548.00 M(+7.5%) | $2.11 B(+2.7%) |
| Dec 1991 | $2.06 B(+17.6%) | $510.00 M(-9.4%) | $2.06 B(+4.3%) |
| Sept 1991 | - | $563.00 M(+14.9%) | $1.97 B(+3.5%) |
| June 1991 | - | $490.00 M(-0.6%) | $1.91 B(+4.0%) |
| Mar 1991 | - | $493.00 M(+15.7%) | $1.83 B(+4.8%) |
| Dec 1990 | $1.75 B(+134.0%) | $426.00 M(-14.1%) | $1.75 B(+80.4%) |
| Sept 1990 | - | $496.00 M(+18.9%) | $969.00 M(+9.6%) |
| June 1990 | - | $417.00 M(+2.0%) | $884.00 M(+8.9%) |
| Mar 1990 | - | $409.00 M(-215.9%) | $812.00 M(+8.7%) |
| Dec 1989 | $747.00 M(-40.4%) | -$353.00 M(-185.9%) | $747.00 M(-46.4%) |
| Sept 1989 | - | $411.00 M(+19.1%) | $1.39 B(+4.2%) |
| June 1989 | - | $345.00 M(+0.3%) | $1.34 B(+3.1%) |
| Mar 1989 | - | $344.00 M(+17.4%) | $1.30 B(+3.4%) |
| Dec 1988 | $1.25 B(+17.4%) | $293.00 M(-17.5%) | $1.25 B(+2.1%) |
| Sept 1988 | - | $355.00 M(+16.4%) | $1.23 B(+7.7%) |
| June 1988 | - | $305.00 M(+1.3%) | $1.14 B(+3.4%) |
| Mar 1988 | - | $301.00 M(+12.7%) | $1.10 B(+3.2%) |
| Dec 1987 | $1.07 B | $267.00 M(0.0%) | $1.07 B(+33.3%) |
| Sept 1987 | - | $267.00 M(0.0%) | $801.00 M(+50.0%) |
| June 1987 | - | $267.00 M(0.0%) | $534.00 M(+100.0%) |
| Mar 1987 | - | $267.00 M | $267.00 M |
FAQ
- What is Bristol-Myers Squibb annual net profit?
- What is the all time high annual net income for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual net income year-on-year change?
- What is Bristol-Myers Squibb quarterly net profit?
- What is the all time high quarterly net income for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly net income year-on-year change?
- What is Bristol-Myers Squibb TTM net profit?
- What is the all time high TTM net income for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM net income year-on-year change?
What is Bristol-Myers Squibb annual net profit?
The current annual net income of BMY is $8.03 B
What is the all time high annual net income for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual net profit is $10.61 B
What is Bristol-Myers Squibb annual net income year-on-year change?
Over the past year, BMY annual net profit has changed by +$1.70 B (+26.84%)
What is Bristol-Myers Squibb quarterly net profit?
The current quarterly net income of BMY is $1.21 B
What is the all time high quarterly net income for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly net profit is $8.03 B
What is Bristol-Myers Squibb quarterly net income year-on-year change?
Over the past year, BMY quarterly net profit has changed by -$717.00 M (-37.19%)
What is Bristol-Myers Squibb TTM net profit?
The current TTM net income of BMY is -$7.26 B
What is the all time high TTM net income for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM net profit is $10.72 B
What is Bristol-Myers Squibb TTM net income year-on-year change?
Over the past year, BMY TTM net profit has changed by -$15.54 B (-187.60%)